Vimarsana
Biggest News Aggregation in the World

Cell Thyroid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Thyroid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Thyroid Today - Breaking & Trending Today

FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc. - Vimarsana News

FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc.

Press release content from Business Wire. The AP news staff was not involved in its creation. FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc. March 2, 2021 GMT WEST CHESTER, Pa.--(BUSINESS WIRE)--Mar 2, 2021-- Molecular Targeting Technologies, Inc. (MTTI), a clinical stage radiopharmaceutical therapy company focused on therapies for rare diseases, announced today the approval of an Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). It enables a Phase I clinical study of the Safety and Dos...

Source: apnews.com